Cancer

April 26, 2023

VICC Scientific Retreat focuses on emerging technologies

The Vanderbilt-Ingram Cancer Center 24th Annual Scientific Retreat will be held from 8:30 am to 3 pm, May 23, in the Vanderbilt Student Life Center.

 

by Tom Wilemon

The Vanderbilt-Ingram Cancer Center 24th Annual Scientific Retreat will focus on “Emerging Technologies in Cancer Research” and feature guest speakers on the subject.

The registration deadline is May 8 for the event, which will be held from 8:30 am to 3 pm, May 23, in the Vanderbilt Student Life Center. Breakfast and lunch will be provided for those who register in advance.

The speakers include Mohammed AlQuraishi, PhD, assistant professor of Systems Biology at Columbia University; Avery Posey Jr., PhD, assistant professor of Systems Pharmacology and  Translational Therapeutics at The University of Pennsylvania; and Sarah Teichmann, FMedSci, FRS, who heads the Cellular Genetics program at the University of Cambridge.

The Vanderbilt-Ingram Postdoctoral Student of the Year and the Graduate Student of the Year will also give highlights about their ongoing research. Other young researchers will showcase their work in a poster and abstract session.

AlQuraishi is a member of Columbia’s Program for Mathematical Genomics, where he works at the intersection of machine learning, biophysics, and systems biology.  Prior to starting his academic career, he spent three years founding two startups in the mobile computing space.

Posey is a member researcher of the Parker Institute for Cancer Immunotherapy and a research health scientist at the Philadelphia Veterans Administration Medical Center. The Posey Laboratory generates novel chimeric antigen receptor T-cell (CAR T) therapies targeting tumor-associated glycosylation and investigates strategies to enhance CAR T-cell persistence and overcome tumor-induced immunosuppression.

Teichmann leads a research group that develops and applies cell atlasing technologies to map human tissue architecture in order to better understand health and disease. In 2016, she cofounded the Human Cell Atlas consortium, which she continues to co-lead. She is also director of research at the Department of Physics at the University of Cambridge.